Literature DB >> 33465012

COVID-19 in spinal cord injury patients at a veterans administration hospital: A case series.

Marinella D Galea1,2,3,4, Michael A Gelman5,6, Vincent P Galea3, Krutika Parasar Raulkar4, Stephen Kornfeld1,2,3,4, Swapna Johnson-Kunjukutty1,3, Gang Li1,2,3, Norbert Bräu1,5,6.   

Abstract

OBJECTIVE: To describe the clinical features and disease course of COVID-19 in veterans with spinal cord injury (SCI).
DESIGN: Case series of consecutive veterans with SCI treated at a single center.
SETTING: SCI Unit at an urban Veterans Administration hospital at the epicenter of the COVID-19 pandemic in the US. PARTICIPANTS: Seven SCI veterans with confirmed COVID-19 infection by PCR; all veterans were male, mean age was 60.6. Five had cervical level of injury, and five had complete injury (AIS A). Six veterans had a BMI > 22; three had chronic obstructive pulmonary disease; three had chronic kidney disease.
INTERVENTIONS: None. OUTCOME MEASURES: Presence of co-morbidities, diagnostic values, and clinical findings.
RESULTS: Each case presented differently; the most common presenting sign was fever. In the three individuals with critical and fatal infection, pre-existing comorbidities were more common and inflammatory markers were markedly elevated.
CONCLUSION: Level and completeness of SCI did not appear to correlate with COVID-19 severity, as mild and asymptomatic illness was noted in persons with high grade SCI. As has been shown to be the case in the general population, pre-existing comorbidities are the most reliable predictors of severe SARS-CoV-2 infection currently available for persons with chronic SCI. Contrary to concerns that SCI may mask the cardinal signs of COVID-19, such as fever and cough, by way of compromised thermoregulation and thoracoabdominal musculature, such signs were common in our series. To facilitate early detection, prompt treatment, and minimized viral spread, the implementation of preventive strategies by SCI units is recommended.

Entities:  

Keywords:  COVID-19; Spinal cord injury

Mesh:

Year:  2021        PMID: 33465012      PMCID: PMC9542337          DOI: 10.1080/10790268.2020.1871254

Source DB:  PubMed          Journal:  J Spinal Cord Med        ISSN: 1079-0268            Impact factor:   2.040


  24 in total

1.  Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections.

Authors:  Quan-Xin Long; Xiao-Jun Tang; Qiu-Lin Shi; Qin Li; Hai-Jun Deng; Jun Yuan; Jie-Li Hu; Wei Xu; Yong Zhang; Fa-Jin Lv; Kun Su; Fan Zhang; Jiang Gong; Bo Wu; Xia-Mao Liu; Jin-Jing Li; Jing-Fu Qiu; Juan Chen; Ai-Long Huang
Journal:  Nat Med       Date:  2020-06-18       Impact factor: 53.440

2.  Spinal cord injury-induced immune depression syndrome (SCI-IDS).

Authors:  Tino Riegger; Sabine Conrad; Kai Liu; Hermann J Schluesener; Mahdi Adibzahdeh; Jan M Schwab
Journal:  Eur J Neurosci       Date:  2007-03       Impact factor: 3.386

3.  Lowering body mass index cutoffs better identifies obese persons with spinal cord injury.

Authors:  G E Laughton; A C Buchholz; K A Martin Ginis; R E Goy
Journal:  Spinal Cord       Date:  2009-04-07       Impact factor: 2.772

4.  Atypical presentation of Covid-19 in persons with spinal cord injury.

Authors:  Madeline A Dicks; Nathan D Clements; C R Gibbons; Monica Verduzco-Gutierrez; Michelle Trbovich
Journal:  Spinal Cord Ser Cases       Date:  2020-05-13

5.  Case-fatality with coronavirus disease 2019 (COVID-19) in United States Veterans with spinal cord injuries and disorders.

Authors:  Stephen P Burns; Adam C Eberhart; Jennifer L Sippel; Geneva M Wilson; Charlesnika T Evans
Journal:  Spinal Cord       Date:  2020-07-27       Impact factor: 2.772

6.  COVID-19 tsunami: the first case of a spinal cord injury patient in Italy.

Authors:  Gabriele Righi; Giulio Del Popolo
Journal:  Spinal Cord Ser Cases       Date:  2020-04-17

Review 7.  COVID-19 Pandemic Causing Acute Kidney Injury and Impact on Patients With Chronic Kidney Disease and Renal Transplantation.

Authors:  Sreedhar Adapa; Avantika Chenna; Mamtha Balla; Ganesh Prasad Merugu; Narayana Murty Koduri; Subba Rao Daggubati; Vijay Gayam; Srikanth Naramala; Venu Madhav Konala
Journal:  J Clin Med Res       Date:  2020-06-04

8.  High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Requiring Invasive Mechanical Ventilation.

Authors:  Arthur Simonnet; Mikael Chetboun; Julien Poissy; Violeta Raverdy; Jerome Noulette; Alain Duhamel; Julien Labreuche; Daniel Mathieu; Francois Pattou; Merce Jourdain
Journal:  Obesity (Silver Spring)       Date:  2020-06-10       Impact factor: 9.298

9.  Clinical, immunological and virological characterization of COVID-19 patients that test re-positive for SARS-CoV-2 by RT-PCR.

Authors:  Jing Lu; Jinju Peng; Qianling Xiong; Zhe Liu; Huifang Lin; Xiaohua Tan; Min Kang; Runyu Yuan; Lilian Zeng; Pingping Zhou; Chumin Liang; Lina Yi; Louis du Plessis; Tie Song; Wenjun Ma; Jiufeng Sun; Oliver G Pybus; Changwen Ke
Journal:  EBioMedicine       Date:  2020-08-24       Impact factor: 8.143

10.  Positive, again! What to make of "re-positive" SARS-CoV-2 molecular test results.

Authors:  Viviana Simon; Harm van Bakel; Emilia Mia Sordillo
Journal:  EBioMedicine       Date:  2020-09-22       Impact factor: 8.143

View more
  3 in total

1.  Spinal cord medicine today: Meeting the challenges of pandemic-era research and care.

Authors:  Carolann Murphy; Florian Thomas
Journal:  J Spinal Cord Med       Date:  2021-11       Impact factor: 1.985

2.  Serving the diverse community of spinal cord injury professionals: Topics and trends in research and care.

Authors:  Florian P Thomas; Carolann Murphy
Journal:  J Spinal Cord Med       Date:  2021-03       Impact factor: 1.985

3.  Outcomes in patients with and without disability admitted to hospital with COVID-19: a retrospective cohort study.

Authors:  Hilary K Brown; Sudipta Saha; Timothy C Y Chan; Angela M Cheung; Michael Fralick; Marzyeh Ghassemi; Margaret Herridge; Janice Kwan; Shail Rawal; Laura Rosella; Terence Tang; Adina Weinerman; Yona Lunsky; Fahad Razak; Amol A Verma
Journal:  CMAJ       Date:  2022-01-31       Impact factor: 16.859

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.